NBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NovaBay Pharmaceuticals, Inc.'s quarterly cash and cash equivalents increased from Jun. 2013 ($6.59 Mil) to Sep. 2013 ($6.93 Mil) and increased from Sep. 2013 ($6.93 Mil) to Dec. 2013 ($10.50 Mil).
NovaBay Pharmaceuticals, Inc.'s annual cash and cash equivalents increased from Dec. 2011 ($8.43 Mil) to Dec. 2012 ($12.74 Mil) but then declined from Dec. 2012 ($12.74 Mil) to Dec. 2013 ($10.50 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
NovaBay Pharmaceuticals, Inc. Annual Data
NovaBay Pharmaceuticals, Inc. Quarterly Data